Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 325


Shear wave elastography can assess the in-vivo nonlinear mechanical behavior of heel-pad.

Chatzistergos PE, Behforootan S, Allan D, Naemi R, Chockalingam N.

J Biomech. 2018 Oct 26;80:144-150. doi: 10.1016/j.jbiomech.2018.09.003. Epub 2018 Sep 10.


Influence of Vitamin D Supplementation by Sunlight or Oral D3 on Exercise Performance.

Carswell AT, Oliver SJ, Wentz LM, Kashi DS, Roberts R, Tang JCY, Izard RM, Jackson S, Allan D, Rhodes LE, Fraser WD, Greeves JP, Walsh NP.

Med Sci Sports Exerc. 2018 Dec;50(12):2555-2564. doi: 10.1249/MSS.0000000000001721.


Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia.

Visram A, Aziz J, Bryant A, Zhang T, Cieniak C, Hamelin L, Landry C, Morris G, Mercer D, Atkins H, Huebsch L, Al-Touri S, Fulcher J, Sabloff M, Kekre N, Bredeson C, Allan D.

Biol Blood Marrow Transplant. 2018 Jul 21. pii: S1083-8791(18)30411-7. doi: 10.1016/j.bbmt.2018.07.022. [Epub ahead of print]


Assessing opportunities and challenges for establishing a national program to distribute cord blood for research.

Isasi R, Mastronardi C, Golder M, Allan D, Walker M, Halpenny M, Yang L, Elmoazzen H, Chargé S.

Transfusion. 2018 Jul;58(7):1726-1731. doi: 10.1111/trf.14602. Epub 2018 Apr 1.


Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers.

Visram A, Bredeson C, Allan D, Sabloff M, Huebsch L, Tay J, Kekre N, McDiarmid S, Mallick R, Tinmouth A, Martin L, Hamelin L, Maze D.

Blood Cancer J. 2018 Jan 29;8(1):14. doi: 10.1038/s41408-018-0050-2. No abstract available.


Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence.

Fingrut W, Rikhraj K, Allan D.

Vox Sang. 2018 May;113(4):307-316. doi: 10.1111/vox.12632. Epub 2018 Jan 22. Review.


Risk of Exposure to Zika Virus and Impact on Cord Blood Banking and Adult Unrelated Donors in Hematopoietic Cell Transplantation: The Canadian Blood Services Experience.

Adams Z, Morris G, Campbell T, Mostert K, Dibdin N, Fearon M, Elmoazzen H, Mercer D, Young K, Allan D.

Biol Blood Marrow Transplant. 2018 Apr;24(4):861-865. doi: 10.1016/j.bbmt.2017.11.032. Epub 2017 Dec 15.


Bereaved family members' perceptions of the quality of end-of-life care across four types of inpatient care settings.

Stajduhar K, Sawatzky R, Robin Cohen S, Heyland DK, Allan D, Bidgood D, Norgrove L, Gadermann AM.

BMC Palliat Care. 2017 Nov 25;16(1):59. doi: 10.1186/s12904-017-0237-5.


Cryopreservation of adult unrelated donor products in hematopoietic cell transplantation: the OneMatch experience and systematic review of the literature.

Aziz J, Morris G, Rizk M, Shorr R, Mercer D, Young K, Allan D.

Transfusion. 2017 Nov;57(11):2782-2789. doi: 10.1111/trf.14360. Epub 2017 Sep 30.


The Stem Cell Club: a model for unrelated stem cell donor recruitment.

Fingrut W, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang YG, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H.

Transfusion. 2017 Dec;57(12):2928-2936. doi: 10.1111/trf.14327. Epub 2017 Sep 24.


Systemic photodynamic therapy in folliculitis decalvans.

Collier NJ, Allan D, Diaz Pesantes F, Sheridan L, Allan E.

Clin Exp Dermatol. 2018 Jan;43(1):46-49. doi: 10.1111/ced.13238. Epub 2017 Sep 22.


Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

Bryant A, Mallick R, Huebsch L, Allan D, Atkins H, Anstee G, Sabloff M, Scrivens N, Maze D, Bredeson C, Kekre N.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2096-2101. doi: 10.1016/j.bbmt.2017.08.007. Epub 2017 Aug 15.


An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells.

Jia D, Li L, Andrew S, Allan D, Li X, Lee J, Ji G, Yao Z, Gadde S, Figeys D, Wang L.

Cell Death Dis. 2017 Jul 13;8(7):e2932. doi: 10.1038/cddis.2017.319.


Clinical Studies of Ex Vivo Expansion to Accelerate Engraftment After Umbilical Cord Blood Transplantation: A Systematic Review.

Kiernan J, Damien P, Monaghan M, Shorr R, McIntyre L, Fergusson D, Tinmouth A, Allan D.

Transfus Med Rev. 2017 Jul;31(3):173-182. doi: 10.1016/j.tmrv.2016.12.004. Epub 2016 Dec 23. Review.


Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia.

Altouri S, Sabloff M, Allan D, Atkins H, Huebsch L, Maze D, Samant R, Bredeson C.

Case Rep Hematol. 2016;2016:1257679. Epub 2016 Nov 13.


Small-Molecule Ice Recrystallization Inhibitors Improve the Post-Thaw Function of Hematopoietic Stem and Progenitor Cells.

Briard JG, Jahan S, Chandran P, Allan D, Pineault N, Ben RN.

ACS Omega. 2016 Nov 30;1(5):1010-1018. doi: 10.1021/acsomega.6b00178. Epub 2016 Nov 28.


Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.

Tay J, Allan D, Beattie S, Bredeson C, Fergusson D, Maze D, Sabloff M, Thavorn K, Tinmouth A.

BMJ Open. 2016 Oct 24;6(10):e013483. doi: 10.1136/bmjopen-2016-013483.


Derivation of the clinical grade human embryonic stem cell line RCe021-A (RC-17).

De Sousa PA, Tye BJ, Bruce K, Dand P, Russell G, Collins DM, Greenshields A, McDonald K, Bradburn H, Allan D, Laurie A, Kunath T, Canham MA, Downie JM, Bateman M, Courtney A.

Stem Cell Res. 2016 Jul;17(1):1-5. doi: 10.1016/j.scr.2016.04.019. Epub 2016 Apr 30.


Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.

Allan D, Fairlie-Clarke KJ, Elliott C, Schuh C, Barnett SC, Lassmann H, Linnington C, Jiang HR.

Acta Neuropathol Commun. 2016 Jul 26;4(1):75. doi: 10.1186/s40478-016-0344-1.


Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.

Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A, Bence-Bruckler I, Birch P, Bredeson C, Chen J, Fergusson D, Halpenny M, Hamelin L, Huebsch L, Hutton B, Laneuville P, Lapierre Y, Lee H, Martin L, McDiarmid S, O'Connor P, Ramsay T, Sabloff M, Walker L, Freedman MS.

Lancet. 2016 Aug 6;388(10044):576-85. doi: 10.1016/S0140-6736(16)30169-6. Epub 2016 Jun 9.


Supplemental Content

Loading ...
Support Center